Reassessing the risks and benefits of COVID-19 precautions in 2023

Oncotarget. 2023 Sep 22:14:819-820. doi: 10.18632/oncotarget.28468.
No abstract available

Keywords: COVID; cancer; immunosuppression.

Publication types

  • Editorial

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Risk Assessment